<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02490631</url>
  </required_header>
  <id_info>
    <org_study_id>150310</org_study_id>
    <nct_id>NCT02490631</nct_id>
  </id_info>
  <brief_title>2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients</brief_title>
  <acronym>DeSSI</acronym>
  <official_title>A Randomized Controlled Trial of 2% Chlorhexidine Gluconate Skin Preparation Cloths for the Prevention of Post op Surgical Site Infections in Spine Patients (Decrease SSI or DeSSI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sage Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical site infection (SSI) following spinal surgery is a frequent complication and results
      in higher morbidity, mortality and healthcare costs. SSI following adult spinal surgery is a
      frequent complication that has been reported to occur in 0.7-12.0% of patients and result in
      higher postoperative morbidity, mortality and health care costs. Vanderbilt University
      Medical Center SSI rate is 7%. Treatment for SSI can be challenging often requiring revision
      surgery, long-term antibiotics, and prolonged hospitalization. The accurate identification of
      risk factors is thus important in the development of strategies to prevent these potentially
      devastating infections. This study proposes a randomized, controlled trial of neuro-spine
      patients of 2% chlorhexidine gluconate skin preparation cloths for the prevention of post op
      surgical site infections in spine patients.

      Use of CHG cloths the night before and morning of surgery (neckline to toes) will affect
      (decrease rates) of SSI compared to patients who receive routine standard of care (soap and
      water pre-op, day of surgery and daily post-operative).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pre-operatively patients scheduled for neurosurgical spine cases will be evaluated and
      approached for interest, if consenting process completed, patients will be randomized to one
      of 2 arms in 1:1 through a block randomization table.

      Those enrolled into the study arm will receive the CHG cloths and instructions for use from
      research personal. Those randomized to the control arm will receive standard of care skin
      cleansing by nursing staff.

      All subjects who have signed consent will have a skin swab culture taken the day of screening
      and prior to cleansing with Chlorhexidine gluconate wipes close to the intended incision
      line. The investigators will also obtain skin swab cultures at site of incision
      preoperatively on the day of surgery, post-op day 4 or time of discharge and at the 30 day
      follow up.

      Both groups will be evaluated daily by study personnel for the development of SSI until
      post-op day 4 or hospital discharge whichever one comes first. After dressing removal, a
      daily high definition picture will be taken of the incision line to further document signs of
      SSI development (pictures will not have any patient identifiable information). Additional
      evaluations will take place at the 30 day (+/- 7 days) post-op visit. Blinded evaluators
      utilizing the CDC guideline will grade the incision line for presence of SSI. Measured change
      in skin flora will be performed by comparing skin swab cultures of intervention group versus
      standard of care group and individual changes pre and post operatively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2015</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 30, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical Site Infection Development at 30 Days Post-operative</measure>
    <time_frame>post op day 30</time_frame>
    <description>Evaluation daily using the CDC guidelines, daily measurements and deidentified photos</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Positive or Abnormal Skin Cultures on Day of Surgery, Day of Discharge, 30 Days Post-op</measure>
    <time_frame>Day of Surgery, Day of Discharge, 30 days post-op</time_frame>
    <description>Skin swabs collected on Day of Surgery, Day of Discharge, 30 days post-op</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">158</enrollment>
  <condition>Surgical Site Infections</condition>
  <condition>Post Operative Complication</condition>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care pre-operative cleansing with soap and water the night before and morning of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2% chlorhexidine gluconate cloths the night before and morning of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% chlorhexidine gluconate cloths</intervention_name>
    <description>Cleansing twice pre-operatively jawline to toes with 2% chlorhexidine gluconate cloths</description>
    <arm_group_label>Intervention Arm</arm_group_label>
    <other_name>SAGE patient preoperative skin preparation cloths</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients scheduled for a neuro-spine procedure and have 2 of the following risk factors:

          -  Diabetic OR

          -  BMI&gt;30 OR

          -  ASA&gt;2 OR

          -  pre-operatively hospitalized OR

          -  &gt;60 years old OR

          -  chronic steroids/immunosuppressive medications OR

          -  prior history of SSI

        Exclusion Criteria:

          -  Unable to consent

          -  Non English speaking

          -  Known allergy to any of the ingredients contained in SAGE chlorhexidine gluconate
             cloths

          -  Current infection or history of spine infections

          -  Patients with tumors or intradural spinal pathology.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Abbey DM, Turner DM, Warson JS, Wirt TC, Scalley RD. Treatment of postoperative wound infections following spinal fusion with instrumentation. J Spinal Disord. 1995 Aug;8(4):278-83.</citation>
    <PMID>8547767</PMID>
  </reference>
  <reference>
    <citation>Balderston RA, Blumberg K (1991) Infection in spine surgery. In: Balderston RA, An HS (eds) Complications in spinal surgery. WB Saunders, Philadelphia, pp 157-168</citation>
  </reference>
  <reference>
    <citation>Glassman SD, Dimar JR, Puno RM, Johnson JR. Salvage of instrumental lumbar fusions complicated by surgical wound infection. Spine (Phila Pa 1976). 1996 Sep 15;21(18):2163-9.</citation>
    <PMID>8893444</PMID>
  </reference>
  <reference>
    <citation>Keller RB, Pappas AM. Infection after spinal fusion using internal fixation instrumentation. Orthop Clin North Am. 1972 Mar;3(1):99-111.</citation>
    <PMID>5012590</PMID>
  </reference>
  <reference>
    <citation>Kostuik JP, Israel J, Hall JE. Scoliosis surgery in adults. Clin Orthop Relat Res. 1973 Jun;(93):225-34.</citation>
    <PMID>4722945</PMID>
  </reference>
  <reference>
    <citation>Lonstein J, Winter R, Moe J, Gaines D. Wound infection with Harrington instrumentation and spine fusion for scoliosis. Clin Orthop Relat Res. 1973 Oct;(96):222-33.</citation>
    <PMID>4584242</PMID>
  </reference>
  <reference>
    <citation>Roberts FJ, Walsh A, Wing P, Dvorak M, Schweigel J. The influence of surveillance methods on surgical wound infection rates in a tertiary care spinal surgery service. Spine (Phila Pa 1976). 1998 Feb 1;23(3):366-70.</citation>
    <PMID>9507627</PMID>
  </reference>
  <reference>
    <citation>West JL 3rd, Ogilvie JW, Bradford DS. Complications of the variable screw plate pedicle screw fixation. Spine (Phila Pa 1976). 1991 May;16(5):576-9.</citation>
    <PMID>2053001</PMID>
  </reference>
  <reference>
    <citation>Olsen MA, Mayfield J, Lauryssen C, Polish LB, Jones M, Vest J, Fraser VJ. Risk factors for surgical site infection in spinal surgery. J Neurosurg. 2003 Mar;98(2 Suppl):149-55.</citation>
    <PMID>12650399</PMID>
  </reference>
  <reference>
    <citation>Calderone RR, Garland DE, Capen DA, Oster H. Cost of medical care for postoperative spinal infections. Orthop Clin North Am. 1996 Jan;27(1):171-82.</citation>
    <PMID>8539047</PMID>
  </reference>
  <reference>
    <citation>Davis H. Increasing rates of cervical and lumbar spine surgery in the United States, 1979-1990. Spine (Phila Pa 1976). 1994 May 15;19(10):1117-23; discussion 1123-4.</citation>
    <PMID>8059266</PMID>
  </reference>
  <reference>
    <citation>Patel N, Bagan B, Vadera S, Maltenfort MG, Deutsch H, Vaccaro AR, Harrop J, Sharan A, Ratliff JK. Obesity and spine surgery: relation to perioperative complications. J Neurosurg Spine. 2007 Apr;6(4):291-7.</citation>
    <PMID>17436915</PMID>
  </reference>
  <reference>
    <citation>Rihn JA, Lee JY, Ward WT. Infection after the surgical treatment of adolescent idiopathic scoliosis: evaluation of the diagnosis, treatment, and impact on clinical outcomes. Spine (Phila Pa 1976). 2008 Feb 1;33(3):289-94. doi: 10.1097/BRS.0b013e318162016e.</citation>
    <PMID>18303461</PMID>
  </reference>
  <reference>
    <citation>Pull ter Gunne AF, van Laarhoven CJ, Cohen DB. Incidence of surgical site infection following adult spinal deformity surgery: an analysis of patient risk. Eur Spine J. 2010 Jun;19(6):982-8. doi: 10.1007/s00586-009-1269-1. Epub 2010 Jan 12.</citation>
    <PMID>20066445</PMID>
  </reference>
  <reference>
    <citation>Pull ter Gunne AF, Cohen DB. Incidence, prevalence, and analysis of risk factors for surgical site infection following adult spinal surgery. Spine (Phila Pa 1976). 2009 Jun 1;34(13):1422-8. doi: 10.1097/BRS.0b013e3181a03013.</citation>
    <PMID>19478664</PMID>
  </reference>
  <reference>
    <citation>Eiselt D. Presurgical skin preparation with a novel 2% chlorhexidine gluconate cloth reduces rates of surgical site infection in orthopaedic surgical patients. Orthop Nurs. 2009 May-Jun;28(3):141-5. doi: 10.1097/NOR.0b013e3181a469db.</citation>
    <PMID>19494763</PMID>
  </reference>
  <reference>
    <citation>Karki S, Cheng AC. Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. J Hosp Infect. 2012 Oct;82(2):71-84. doi: 10.1016/j.jhin.2012.07.005. Epub 2012 Aug 11. Review.</citation>
    <PMID>22889522</PMID>
  </reference>
  <reference>
    <citation>Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, Weinstein RA, Sepkowitz KA, Jernigan JA, Sanogo K, Wong ES. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med. 2013 Feb 7;368(6):533-42. doi: 10.1056/NEJMoa1113849. Erratum in: N Engl J Med. 2013 Jun 13;368(24):2341.</citation>
    <PMID>23388005</PMID>
  </reference>
  <reference>
    <citation>Milstone AM, Elward A, Song X, Zerr DM, Orscheln R, Speck K, Obeng D, Reich NG, Coffin SE, Perl TM; Pediatric SCRUB Trial Study Group. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet. 2013 Mar 30;381(9872):1099-106. doi: 10.1016/S0140-6736(12)61687-0. Epub 2013 Jan 28.</citation>
    <PMID>23363666</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>June 16, 2015</study_first_submitted>
  <study_first_submitted_qc>July 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2015</study_first_posted>
  <results_first_submitted>February 11, 2020</results_first_submitted>
  <results_first_submitted_qc>February 11, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 25, 2020</results_first_posted>
  <last_update_submitted>February 11, 2020</last_update_submitted>
  <last_update_submitted_qc>February 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Elizabeth Card</investigator_full_name>
    <investigator_title>Nursing Research Consultant</investigator_title>
  </responsible_party>
  <keyword>skin flora</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/31/NCT02490631/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard of Care Pre-operative Cleansing</title>
          <description>Standard of care pre-operative cleansing with soap and water the night before and morning of surgery</description>
        </group>
        <group group_id="P2">
          <title>2% Chlorhexidine Gluconate</title>
          <description>2% chlorhexidine gluconate cloths the night before and morning of surgery
2% chlorhexidine gluconate cloths: Cleansing twice pre-operatively jawline to toes with 2% chlorhexidine gluconate cloths</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
                <participants group_id="P2" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
                <participants group_id="P2" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard of Care Pre-operative Cleansing</title>
          <description>Standard of care pre-operative cleansing with soap and water the night before and morning of surgery</description>
        </group>
        <group group_id="B2">
          <title>2% Chlorhexidine Gluconate</title>
          <description>2% chlorhexidine gluconate cloths the night before and morning of surgery
2% chlorhexidine gluconate cloths: Cleansing twice pre-operatively jawline to toes with 2% chlorhexidine gluconate cloths</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="76"/>
            <count group_id="B2" value="75"/>
            <count group_id="B3" value="151"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="76"/>
                    <count group_id="B2" value="75"/>
                    <count group_id="B3" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63" lower_limit="57" upper_limit="71.25"/>
                    <measurement group_id="B2" value="66" lower_limit="61" upper_limit="72"/>
                    <measurement group_id="B3" value="64" lower_limit="57" upper_limit="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="76"/>
                    <count group_id="B2" value="75"/>
                    <count group_id="B3" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="74"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="76"/>
                    <count group_id="B2" value="75"/>
                    <count group_id="B3" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="75"/>
                    <measurement group_id="B3" value="151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Surgical Site Infection Development at 30 Days Post-operative</title>
        <description>Evaluation daily using the CDC guidelines, daily measurements and deidentified photos</description>
        <time_frame>post op day 30</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care Pre-operative Cleansing</title>
            <description>Standard of care pre-operative cleansing with soap and water the night before and morning of surgery</description>
          </group>
          <group group_id="O2">
            <title>2% Chlorhexidine Gluconate</title>
            <description>2% chlorhexidine gluconate cloths the night before and morning of surgery
2% chlorhexidine gluconate cloths: Cleansing twice pre-operatively jawline to toes with 2% chlorhexidine gluconate cloths</description>
          </group>
        </group_list>
        <measure>
          <title>Surgical Site Infection Development at 30 Days Post-operative</title>
          <description>Evaluation daily using the CDC guidelines, daily measurements and deidentified photos</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.456</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Positive or Abnormal Skin Cultures on Day of Surgery, Day of Discharge, 30 Days Post-op</title>
        <description>Skin swabs collected on Day of Surgery, Day of Discharge, 30 days post-op</description>
        <time_frame>Day of Surgery, Day of Discharge, 30 days post-op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care Pre-operative Cleansing</title>
            <description>Standard of care pre-operative cleansing with soap and water the night before and morning of surgery</description>
          </group>
          <group group_id="O2">
            <title>2% Chlorhexidine Gluconate</title>
            <description>2% chlorhexidine gluconate cloths the night before and morning of surgery
2% chlorhexidine gluconate cloths: Cleansing twice pre-operatively jawline to toes with 2% chlorhexidine gluconate cloths</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Positive or Abnormal Skin Cultures on Day of Surgery, Day of Discharge, 30 Days Post-op</title>
          <description>Skin swabs collected on Day of Surgery, Day of Discharge, 30 days post-op</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>day of surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>day of discharge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 days post-op</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.019</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Standard of Care Pre-operative Cleansing</title>
          <description>Standard of care pre-operative cleansing with soap and water the night before and morning of surgery</description>
        </group>
        <group group_id="E2">
          <title>2% Chlorhexidine Gluconate</title>
          <description>2% chlorhexidine gluconate cloths the night before and morning of surgery
2% chlorhexidine gluconate cloths: Cleansing twice pre-operatively jawline to toes with 2% chlorhexidine gluconate cloths</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>larger sample size needed to examine the relationship between normal skin cultures in the Chlorhexidine arm vs control and development of surgical site infections by day 30.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Elizabeth Card</name_or_title>
      <organization>Vanderbilt University Medical Center</organization>
      <phone>615-875-4611</phone>
      <email>elizabeth.b.card@vumc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

